Vanguard Capital Management’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.3M Sell
7,812,919
-364,833
-4% -$1.12M ﹤0.01% 2336
2026
Q2
$24.9M Buy
8,177,752
+2,519,703
+45% +$7.53M ﹤0.01% 2328
2026
Q1
$17.4M Buy
+5,658,049
New +$24M ﹤0.01% 2423

Other funds holding ALT

Vanguard Capital Management's ALT Position: Q3 2026 in Review

Vanguard Capital Management reduced its Altimmune (ALT) stake by 4.5% in Q3 2026, selling an estimated $1.12M and leaving 7,812,919 shares worth $22.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2336.

Vanguard Capital Management first reported a position in ALT in Q1 2026 and has held it in 3 quarters since. The position peaked at $24.9M in Q2 2026. 191 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • Vanguard Capital Management held 7,812,919 shares of Altimmune worth $22.3M as of Q3 2026.
  • Vanguard Capital Management sold 364,833 Altimmune shares in Q3 2026, an estimated $1.12M.
  • Altimmune made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2336 holding.
  • Vanguard Capital Management first reported a position in Altimmune in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Altimmune position peaked at $24.9M in Q2 2026.
  • 191 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.